All three opioid peptides plus ANF and noradrenaline were elevated in acute heart failure patients, with higher levels correlating to greater severity.
5 hormones, all elevatedANF, beta-endorphin, met-enkephalin, dynorphin, and noradrenaline all rose in heart failure — a coordinated multi-system response
What the researchers found
ANF, beta-endorphin, met-enkephalin, dynorphin, and noradrenaline were all elevated in acute CHF. Higher levels correlated with greater severity.
Why it matters
Heart failure activates multiple peptide systems. Understanding this coordinated response could lead to better biomarker panels for assessing heart failure severity and guiding treatment.
How the study worked
Plasma samples from 20 acute CHF patients (stratified by severity) and 20 controls were analyzed for ANF, three opioid peptides, and noradrenaline by immunoassay.
What this study cannot tell us
Cross-sectional study with relatively small groups. Plasma levels measured at one time point. Cannot determine if elevated opioids are beneficial or harmful.
How to read the evidence
Moderate — cross-sectional study with matched groups. Small sample but consistent elevation across multiple biomarkers.
When this study was published
Published in 1993 (33 years ago). ANF/BNP are now standard heart failure biomarkers; opioid peptide elevation in CHF has been confirmed.
The bigger picture
Heart failure doesn't just stress the heart — it activates the body's pain system, stress system, and cardiovascular peptide system simultaneously. Multi-marker panels could better predict outcomes than any single hormone measurement.
Questions still open
- Are the elevated opioid peptides protective or contributing to heart failure symptoms?
- Could a multi-peptide biomarker panel better predict heart failure outcomes?
Common questions
Why does heart failure raise opioid levels?
Could measuring opioid levels help manage heart failure?
Read the original research
Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with acute congestive heart failure.
European heart journal, 14(2), 219-25
Citation
Fontana, F; Bernardi, P; Pich, E M; Capelli, M; Bortoluzzi, L; Spampinato, S; Canossa, M. (1993). Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with acute congestive heart failure.. European heart journal, 14(2), 219-25.